EUVIMEDEUVIMED entdecken
Crossref

Chicken‐Derived Single‐Chain Variable Fragments Targeting Monkeypox Virus A29L Protein

Chi-Hsin Lee iD, Chao-Jung Wu, Jia-Yun Chiang, Fang-Yi Yen, Ting-Jing Shen, Sy-Jye Leu, Bor-Yu Tsai, Yan-Chiao Mao, Valencia Andriani, Wei-Chu Wang, Priskila Cherisca Thenaka iD, Yu-Pin Chao und 1 weitere

Biotechnology Journal · 2025-02 · 20 (2)

DOI: 10.1002/biot.202400634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 24.02.2025. Verfasst von Chi-Hsin Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Monkeypox virus, Viral Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monkeypox (mpox), a zoonotic disease, has rapidly spread globally, prompting the WHO to declare it a public health emergency. The long incubation period, early symptoms resembling respiratory infections, and diagnostic challenges hinder timely epidemic control and accurate clinical diagnosis. The monkeypox virus (MPXV) encodes the A29L protein, which binds to cellular heparan sulfate to facilitate infection and serves as a target for treatment and diagnostics. Thus, developing effective diagnostic tools and treatments is critically important. In this study, we expressed and purified Escherichia coli ‐derived A29L protein, which was used for chicken immunization to generate specific polyclonal IgY antibodies. The results demonstrated a successful elicitation of a humoral immune response. Subsequently, two single‐chain variable fragments (scFv) antibody libraries were constructed using phage display technology, comprising 2.6 × 10 8 and 3.8 × 10 8 transformants. After bio‐panning, phage‐based ELISA indicated the enrichment of specific clones. Three scFv‐expressing clones, including cA29LS1, cA29LS5, and cA29LS13, were selected from 13 randomly chosen clones and classified based on nucleotide sequence analysis. Their binding activities were evaluated through ELISA and Western blot, followed by purification for affinity determination via competitive ELISA. Among the selected clones, cA29LS5 demonstrated the highest binding affinity (1.3 × 10⁻⁶ M), followed by cA29LS1 (5.3 × 10⁻⁶ M). Additionally, both IgY and all three clones demonstrated binding activity to cell‐derived and commercially purchased A29L proteins, as confirmed by Western blot and ELISA. Overall, these findings suggested that the IgY and scFv antibodies developed hold promise as potential diagnostic and therapeutic agents against MPXV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Chain AntibodiesMonkeypox virusViral ProteinsAnimalsChickensAntibodies, ViralImmunoglobulinsEscherichia coliMpox, MonkeypoxPeptide LibraryEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

IgY antibodiesmonkeypox (mpox)monkeypox virus (MPXV)phage display technologysingle‐chain variable fragment (scFv) antibody

Substanzen

Single-Chain AntibodiesAntibodies, ViralIgYImmunoglobulinsViral ProteinsPeptide Library

Autor:innen und Institutionen

  • School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • PhD Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University Inc., Taipei, Taiwan.
  • Core Laboratory of Antibody Generation and Research, Taipei Medical University, Taipei, Taiwan.
  • Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Navi Bio-Therapeutics Inc., Taipei, Taiwan.
  • Division of Clinical Toxicology, Department of Emergency Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

ORCID-Profile: Chi-Hsin Lee, Priskila Cherisca Thenaka, Yi-Yuan Yang

Förderung

  • National Science and Technology Council, Taiwan
  • National Science and Technology Council

Zitieren

APA

Lee, C. H., Wu, C. J., Chiang, J. Y., Yen, F. Y., Shen, T. J., Leu, S. J., Tsai, B. Y., Mao, Y. C., Andriani, V., Wang, W. C., Thenaka, P. C., Chao, Y. P., & Yang, Y. Y. (2025). Chicken‐Derived Single‐Chain Variable Fragments Targeting Monkeypox Virus A29L Protein. Biotechnology Journal, 20(2). https://doi.org/10.1002/biot.202400634

Vancouver

Lee CH, Wu CJ, Chiang JY, Yen FY, Shen TJ, Leu SJ, et al. Chicken‐Derived Single‐Chain Variable Fragments Targeting Monkeypox Virus A29L Protein. Biotechnology Journal. 2025;20(2). doi:10.1002/biot.202400634

BibTeX
@article{Lee2025,
  author = {Lee, Chi-Hsin and Wu, Chao-Jung and Chiang, Jia-Yun and Yen, Fang-Yi and Shen, Ting-Jing and Leu, Sy-Jye and Tsai, Bor-Yu and Mao, Yan-Chiao and Andriani, Valencia and Wang, Wei-Chu and Thenaka, Priskila Cherisca and Chao, Yu-Pin and Yang, Yi-Yuan},
  title = {Chicken‐Derived Single‐Chain Variable Fragments Targeting Monkeypox Virus A29L Protein},
  journal = {Biotechnology Journal},
  year = {2025},
  volume = {20},
  number = {2},
  doi = {10.1002/biot.202400634}
}
Kostenlos starten →